Prevalence of metabolic dysfunction‐associated steatotic liver disease in people living with HIV and on antiretroviral treatment: A systematic review and meta‐analysis protocol

Documenti analoghi

• The Prevalence of Cardiovascular Disease Risk Factors on Diabetic Human Immunodeficiency Virus‐Infected Individuals on Antiretroviral Treatment: A Systematic Review and Meta‐Analysis Protocol
  di: Khanyisa Maswanganyi, et al.
  Pubblicazione: (2025)
• The Impact of Selected Regimens of Chronic HIV‐Antiretroviral Treatment on Glycemic Control Markers and Correlates: A Systematic Review and Meta‐Analysis Protocol
  di: Mlindeli Gamede, et al.
  Pubblicazione: (2025)
• Prevalence of metabolic dysfunction‐associated steatotic liver disease in the Middle East and North Africa
  di: Zobair M. Younossi, et al.
  Pubblicazione: (2024)
• Therapeutic management of metabolic dysfunction associated steatotic liver disease
  di: Jing Zeng, et al.
  Pubblicazione: (2024)
• Prevalence of non‐communicable diseases among household contacts of people with tuberculosis: A systematic review and individual participant data meta‐analysis
  di: Yohhei Hamada, et al.
  Pubblicazione: (2024)